Visitor Monitoring Drug History: PROZAC
 
Drugs Directory of False Positives DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST
 
Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Label and Approval History

Drug Name: PROZAC
FDA Application No: (NDA) 018936
Active Ingredient(s): FLUOXETINE HYDROCHLORIDE
Company: LILLY
 
Label History
 
View the label approved on August 3, 2007 for PROZAC, (NDA) 018936


To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.
 
 
 
Approval History
 
Action DateSupplement NumberSort imageApproval TypeLetters, Reviews, Labels, Patient Package Insert
8/2/2007 082Labeling Revision Letter
Label 
8/2/2007 081Labeling Revision Letter
Label 
3/15/2007 078Labeling Revision Letter 
9/20/2006 076Labeling Revision Label 
4/11/2006 074Labeling Revision Letter 
12/1/2005 073Labeling Revision Letter 
2/18/2005 072Labeling Revision Letter 
12/1/2005 071Labeling Revision Letter 
9/3/2004 070Labeling Revision Letter 
8/19/2004 069Labeling Revision Letter 
6/12/2002 067New Dosage Regimen Letter
Label 
7/29/2002 065Efficacy Supplement with Clinical Data to Support  
1/3/2003 064Patient Population Altered Letter
Label
Review 
11/28/2000 063Labeling Revision Review 
11/28/2000 062Labeling Revision Review 
11/28/2000 060Labeling Revision Review 
6/16/1999 059Labeling Revision  
7/6/2000 058New or Modified Indication Letter
Label 
2/11/1999 057Manufacturing Change or Addition  
10/20/1998 056Control Supplement  
6/15/1999 054Formulation Revision Review 
5/29/1998 053Manufacturing Change or Addition  
10/7/1999 052Labeling Revision Review 
3/13/1998 051Labeling Revision  
7/6/1998 050Manufacturing Change or Addition  
4/3/1998 049Package Change  
9/17/1997 046Control Supplement  
12/30/1996 043Manufacturing Change or Addition  
9/12/1995 040Labeling Revision  
3/1/1995 039Control Supplement  
9/12/1995 038Labeling Revision  
3/1/1995 037Labeling Revision  
3/25/1997 036Labeling Revision Review 
7/6/1994 034Labeling Revision  
1/9/1995 033Manufacturing Change or Addition  
3/25/1993 032Labeling Revision  
8/18/1993 031Labeling Revision  
8/20/1992 030Labeling Revision  
1/21/1992 028Labeling Revision  
1/21/1992 027Labeling Revision  
12/23/1992 026Formulation Revision  
1/21/1992 025Labeling Revision  
4/9/1991 024Labeling Revision  
4/9/1991 023Labeling Revision  
6/7/1990 022Labeling Revision  
6/7/1990 021Labeling Revision  
6/7/1990 020Labeling Revision  
6/7/1990 019Labeling Revision  
6/7/1990 018Labeling Revision  
6/7/1990 017Labeling Revision  
6/7/1990 016Labeling Revision  
6/7/1990 015Labeling Revision  
2/8/1989 014Control Supplement  
2/16/1989 013Labeling Revision  
2/17/1989 012Control Supplement  
11/17/1988 011Labeling Revision  
11/17/1988 009Labeling Revision  
10/26/1988 008Manufacturing Change or Addition  
6/22/1988 007Labeling Revision  
9/28/1988 006Package Change  
11/21/1996 004New or Modified Indication  
9/28/1988 003Control Supplement  
5/6/1988 002Control Supplement  
12/29/1987 000Approval Other Important Information from FDA 
 
©2019 Drugs That Causes a False Positive on a Drug Test